Purpose: Our study will analyze patients' clinical characteristics, treatment strategies, and complications with deep neck infection (DNI) using their medical records for five years.Methods: The present study included 111 patients diagnosed with DNI in our clinic between January 2018 and March 2023. The patients' complaints at admission, sociodemographic characteristics, season of diagnosis, findings from laboratory tests, radiological imaging performed at the time of first diagnosis, abscess localization, medical and surgical treatment methods used, and complications developing during follow‐up were retrospectively examined.Results: The mean age of the patients included in the study was 38.51 ± 16.92 (6–87 years). There was a significant correlation between chronic disease, smoking behaviours, oral hygiene, and DNI among patients based on their sociodemographic characteristics and medical history (p < .005). DNI development did not differ by season (p > .005). Physical examination findings predominantly revealed neck masses (39.6%) and peritonsillar abscesses (32.4%), and patients with peritonsillar abscesses had a shorter length of hospital stay than those with other localizations. No severe complications occurred during the clinical follow‐up.Conclusion: Chronic diseases, smoking, and poor oral hygiene are the primary risk factors for developing DNIs. If an abscess is located in a critical area, it may require extended hospitalization and surgery under general anesthesia. Therefore, addressing these risk factors and encouraging good oral hygiene practices are crucial to preventing DNIs and reducing the need for intensive treatment.
3 September 2019 in The Journal of International Advanced Otology
OBJECTIVE: To evaluate the effects of resveratrol on tympanosclerosis in an experimental rat model by otomicroscopic, histopathological, and immunohistochemical examinations, and measurement of malondialdehyde levels. MATERIALS and METHODS: Twenty albino Wistar rats were used in the study. Four were randomly selected as negative controls, with no treatment or intervention. The ears of 16 rats were inoculated with Streptococcus pneumonia Type 3. They were divided into two Groups: resveratrol, at 20 mg/kg/day dissolved in 10% ethanol, was administered orally to the resveratrol Group for 6 weeks; 10% ethanol was administered to the control Group in the same manner. Blood samples were taken for malondialdehyde measurements after the first and sixth weeks. After otomicroscopic examinations, rats were sacrificed at the end of 6 weeks for histopathological and immunohistochemical (matrix metalloproteinases 2 and 9) examinations. Livers of rats were removed for malondialdehyde measurements. RESULTS: Otomicroscopic and histopathological evaluations revealed no significant difference between the Groups. Plasma malondialdehyde level of the resveratrol Group in the first week was lower than that of the control Group (p<0.05). There was no difference in plasma and liver tissue malondialdehyde levels after 6 weeks. There was a significant difference in staining for matrix metalloproteinase 9 of tympanic membranes between the resveratrol and control Groups (p<0.05). CONCLUSION: Resveratrol has potential antioxidant activity and significantly decreases malondialdehyde levels in the first week. It has an inhibitory effect on matrix metalloproteinase 9. However, it appears to be ineffective in the prevention of tympanosclerosis when used alone, according to otomicroscopic and histopathological evaluations.
28 August 2020 in European Journal of Rhinology and Allergy